PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist-Led Audit and Feedback Doubles Timely IV-to-Oral Switch in Oncology Inpatients

antimicrobial stewardshipprospective audit and feedbackintravenous to oral switchoncologypiperacillin-tazobactamceftriaxoneamoxicillin-clavulanateretrospective cohortnursing timeclinical pharmacy practice Clinical Pharmacy Practice

Background Information

Antimicrobial stewardship boosts efficient antibiotic use in oncology wards.

Antimicrobial stewardship (AMS) interventions can optimize antimicrobial use, reducing unnecessary nursing time and hospital resources in oncology settings. AMS prospective audit and feedback increased IV to oral switch rates from 40.8% to 72.5% and decreased antimicrobial use and nursing administration time. This study shows that AMS can safely improve antimicrobial management, though its single-center design may limit generalizability. Prospective audit and feedback significantly improve IV to oral antimicrobial switch rates in oncology patients.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Singh NR, Spelman T, Howell J, Luo C, Machray K, Tran T, Hussainy SY, Lim CX, Lingaratnam S, Douglas AP, Thursky KA, Haeusler GM

Citation: Singh NR, Spelman T, Howell J, et al. Antimicrobial stewardship prospective audit and feedback improves uptake of intravenous to oral antimicrobial switch in oncology inpatients: a cohort study. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e310. doi:10.1017/ash.2026.10880

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.